Surgery utilizes Levita MARS Platform and its Dynamic Magnetic Positioning™ technology and Da Vinci Single Port Robotic System to deliver unprecedented precision and set a new standard for minimally ...
At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...
Stockhead on MSN
ASX healthcare stocks advance new approaches to prostate cancer
ASX-listed healthcare companies are advancing new approaches to prostate cancer, spanning imaging, targeted therapies and surgical nerve repair. ... Read More The post ASX healthcare stocks advance ...
Hospital says locally based team reducing need for overseas treatment By Chioma Obinna In a development highlighting Nigeria’s growing capacity for advanced cancer treatment, Kelina Hospital has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results